Blog | HemaCare

Tumor Cell–Loaded Dendritic Cells Improve Adoptive T-Cell Therapy

Dec 19, 2016 12:00:00 AM / by Stacy Matthews Branch, DVM, PhD posted in dendritic cell vaccine, Dendritic cells, prostate cancer, prostate cancer treatment, research

0 Comments

Tumor-specific cytotoxic T cells are used in patients with cancer with the goal of providing specific recognition and destruction of tumor cells. In adoptive T cell therapy, tumor-specific T cells are collected and multiplied (expanded) outside the body. This is done to obtain a much larger number of the tumor-specific T cells that the patient can be treated with more successfully.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts